AIM
EVH icon

Alambic Investment Management’s Evolent Health EVH Stock Holding History

Alambic Investment Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-16,222
Closed -$129K – 316
2019
Q2 		$129K Buy
+16,222
New +$192K 0.08% 258

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Alambic Investment Management's EVH Position: Q3 2019 in Review

Alambic Investment Management sold out of Evolent Health (EVH) in Q3 2019, closing a stake of 16,222 shares — an estimated $129K sold.

Alambic Investment Management first reported a position in EVH in Q2 2019 and held it in 1 quarter. The position peaked at $129K in Q2 2019. 174 funds tracked by Wall St. Rank hold EVH as of Q3 2019.

  • Alambic Investment Management reported no remaining Evolent Health position as of Q3 2019 after selling out during the quarter.
  • Alambic Investment Management sold 16,222 Evolent Health shares in Q3 2019, an estimated $129K.
  • Alambic Investment Management first reported a position in Evolent Health in Q2 2019 and held it in 1 quarter.
  • Alambic Investment Management's Evolent Health position peaked at $129K in Q2 2019.
  • 174 funds tracked by Wall St. Rank held Evolent Health as of Q3 2019.

Based on Alambic Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.